Figure 1From: Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosisThe 5-year overall survival of IDO-positive and IDO-negative patients with AML is shown.Back to article page